Related Experiment Video
Updated: Jul 8, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle
Joachim Lupberger1, Laurent Brino, Thomas F Baumert
1Inserm, U 748, Strasbourg, France.
Insights
This study identified 26 host genes crucial for hepatitis C virus (HCV) replication, revealing that RNA interference (RNAi) pathway components, including DICER, inhibit HCV, contrary to prior hypotheses. The findings highlight the complex interplay between host factors and viral dynamics.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Hepatitis C virus (HCV) infection and replication are influenced by host cellular factors.
- The development of cell culture-infectious HCV isolates allows for the genetic evaluation of virus-host interactions.
Discussion:
- A systematic RNA interference (RNAi) screen identified 62 host genes interacting with HCV RNA or proteins, or involved in modulating infection.
- Ten host proteins were newly identified as binding to HCV NS5A.
- siRNAs targeting 26 host genes significantly altered infectious HCV production (>3-fold).
Key Insights:
- Contrary to expectations, siRNAs targeting DICER, a key RNAi component, inhibited HCV replication, suggesting RNAi's role is not solely antiviral in this context.
- Several other RNAi pathway components also demonstrated inhibitory effects on HCV replication.
- MicroRNA-122 (miR-122) was identified as the predominant microRNA in liver and hepatoma cells, and its depletion also inhibited HCV replication.
Outlook:
- The study defines 26 host genes that modulate HCV infection.
- The findings indicate that functional RNAi is essential for HCV replication, overriding potential antiviral activities of the pathway.
- Further research can explore these host factors and RNAi interactions for therapeutic strategies against HCV.
Abstract:
Cellular cofactors affecting hepatitis C virus infection and replication. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM. Recently identified hepatitis C virus (HCV) isolates that are infectious in cell culture provide a genetic system to evaluate the significance of virus-host interactions for HCV replication. We have completed a systematic RNAi screen wherein siRNAs were designed that target 62 host genes encoding proteins that physically interact with HCV RNA or proteins or belong to cellular pathways thought to modulate HCV infection. This includes 10 host proteins that we identify in this study to bind HCV NS5A. siRNAs that target 26 of these host genes alter infectious HCV production >3-fold. Included in this set of 26 were siRNAs that target DICER, a principal component of the RNAi silencing pathway. Contrary to the hypothesis that RNAi is an antiviral pathway in mammals, as has been reported for subgenomic HCV replicons, siRNAs that target DICER inhibited HCV replication. Furthermore, siRNAs that target several other components of the RNAi pathway also inhibit HCV replication. MicroRNA profiling of human liver, human hepatoma Huh7.5 cells, and Huh7.5 cells that harbor replicating HCV demonstrated that miR-122 is the predominant microRNA in each environment. miR-122 has been previously implicated in positively regulating the replication of HCV genotype 1 replicons. We find that 2'-O-methyl antisense oligonucleotide depletion of miR-122 also inhibits HCV genotype 2a replication and infectious virus production. Our data define 26 host genes that modulate HCV infection and indicate that the requirement for functional RNAi for HCV replication is dominant over any antiviral activity this pathway may exert against HCV. [Abstract reproduced by permission of Proc Natl Acad Sci USA 2007;104:12884-12889]
Related Concept Videos
Viruses with RNA Genomes
Hepatitis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Retrovirus Life Cycles

